5 completed. 5 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 5 |
Follow PD-1: new trials by email Literature Review of PD-1 trials Research Report on PD-1
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| SCRT+mFOLFOX6+PD-1 Antibody and Targeted Therapy for High-Risk pMMR/MSS Rectal Cancer Short-Course Radiotherapy, PD-1 monoclonal antibody, mFOLFOX6 regimen - Rectal Adenocarcinoma, High-Risk Cancer | Phase 2 | Completed | Sixth Affiliated Hospital, Sun Yat-sen University | 49 | 2025-04-02 | 2026-08-04 |
| HAIC Combine With Lenvatinib and PD-1 Inhibitors for Advanced HCC With PVTT HAIC, Lenvatinib 1, PD-1 Inhibitors - Hepatocellular Carcinoma, Portal Vein Thrombosis | Phase 2 | Completed | Peking University | 66 | 2022-01-10 | 2026-01-23 |
| Apatinib Combined With PD-1 in the Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma Apatinib mesylate tablet, PD-1 - Nasopharyngeal Carcinoma | Phase 2 | Completed | Wei Jiang | 25 | 2021-01-14 | 2023-01-13 |
| Primary Excision Combined With Preoperative Neoadjuvant and Adjuvant Therapy for Oligometastasis of Urothelial Carcinoma primary focal resection plus lymph node dissection, Tislelizumab, Gemcitabine plus cisplatin - Bladder Urothelial Carcinoma | Phase 2 | Completed | The First Affiliated Hospital with Nanjing Medical University | 30 | 2020-12-01 | 2025-08-05 |
| SBRT + PD-1/PDL-1 Inhibiting Therapy for Advanced Solid Tumors After Dz Control on PD-1/PDL-1 Tx Stereotactic radiotherapy, Biological: humanized anti-PD-1 monoclonal antibody, Biological: humanized anti-PD-L1 monoclonal antibody - Solid Tumor | Phase 2 | Completed | Virginia Commonwealth University | 5 | 2017-10-10 | 2022-01-10 |
Carcinoma, Hepatocellular (1) · Nasopharyngeal Carcinoma (1) · Rectal Neoplasms (1)
Peking University (1) · Sixth Affiliated Hospital, Sun Yat-sen University (1) · The First Affiliated Hospital with Nanjing Medical University (1) · Virginia Commonwealth University (1) · Wei Jiang (1)
China (4) · United States (1)
Alfredo Urdaneta, M.D. (1) · Juan Huang, PhD. (1) · Qiang Lv (1) · Wei Jiang, Ph.D. (1) · Xiaodong Wang, MD (1)
P30CA016059 (1)